Key Finding
LbGP supplementation significantly improved oocyte quality in aged mice by restoring mitochondrial function through PPAR signaling activation and remodeling the ovarian microenvironment by reducing inflammation and increasing functional granulosa cells.
Researchers investigated whether Lycium barbarum glycopeptide (LbGP), a natural compound extracted from goji berries, could improve egg quality in older female mice. Goji berries have been used in traditional Chinese medicine for centuries to support healthy aging and reduce inflammation. As women age, egg quality naturally declines, making conception more difficult and increasing risks during pregnancy. This study examined whether LbGP supplementation could reverse some of these age-related changes.
The research team gave LbGP supplements to naturally aged female mice and then carefully analyzed their ovarian function, egg quality, and early embryo development. They used advanced laboratory techniques including live-cell imaging, protein analysis, and genetic sequencing to understand exactly how LbGP works at the cellular level.
The results were promising. Mice receiving LbGP showed significantly better follicle development and produced higher-quality eggs compared to untreated aged mice. The eggs also had better fertilization rates and developed into healthier early embryos. The researchers discovered that LbGP works through two mechanisms: it restores energy-producing mitochondria inside the eggs while simultaneously improving the overall ovarian environment by reducing inflammation and supporting healthy cell populations.
For women concerned about age-related fertility decline, this research suggests that natural compounds like LbGP may offer supportive benefits alongside conventional fertility treatments. Many practitioners integrate herbal medicine with acupuncture protocols for fertility support, as traditional Chinese medicine views reproductive health holistically. If you're considering acupuncture or herbal medicine for fertility concerns, consult with a qualified practitioner who is licensed and board-certified in acupuncture and Chinese herbal medicine.
This study evaluated Lycium barbarum glycopeptide (LbGP) supplementation in naturally aged female mice as a therapeutic intervention for reproductive senescence. Researchers employed histological analysis, in vitro fertilization, proteomic profiling, and single-cell RNA sequencing of ovarian tissues to assess mechanistic pathways. LbGP supplementation significantly enhanced follicular development, oocyte maturation competence, and early embryonic developmental potential compared to age-matched controls. Proteomic analysis revealed LbGP activated PPAR signaling pathways, restoring mitochondrial function and reducing reactive oxygen species accumulation and DNA damage in aged oocytes. Single-cell transcriptomics demonstrated systemic remodeling of the aged ovarian microenvironment, including increased functional granulosa cell populations, reduced pro-inflammatory immune infiltration, and restoration of intercellular communication networks. Clinical relevance: LbGP represents a promising adjunctive therapy for women of advanced maternal age experiencing diminished ovarian reserve. The dual mechanism—intrinsic oocyte metabolic restoration and extrinsic microenvironment optimization—aligns with TCM principles of tonifying Kidney essence while clearing inflammation. Consider integrating standardized LbGP formulations in fertility protocols alongside acupuncture treatment.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 A systematic review of 214 studies found that acupuncture and moxibustion improve endometrial receptivity in IVF-ET patients by enhancing uterine lining thickness, blood flow, and hormone levels through multiple molecular mechanisms including VEGF-mediated angiogenesis and AMPK/mTOR autophagy pathways.
📌 Live birth rate — the outcome most important to patients undergoing acupuncture-assisted IVF — remains one of the least-supported measures in existing clinical trial evidence, highlighting a critical gap between research priorities and patient concerns.
📌 Acupoint application therapy significantly increased high-quality embryo rates to 47% in ovarian endometriosis IVF patients compared to 31% in the placebo group, while normalizing dysregulated follicular steroid hormone levels linked to impaired oocyte yield.